Measurement of liver T1 and T2 relaxation times in an experimental mouse model of liver fibrosis

To characterize changes in relaxation times of liver using quantitative magnetic resonance imaging (MRI) in an experimental mouse model of liver fibrosis. Quantitative MRI is a potentially robust method to characterize liver fibrosis. However, correlation between relaxation times and fibrosis stage has been controversial.

[1]  Daniel Kim,et al.  Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia , 2011, Journal of magnetic resonance imaging : JMRI.

[2]  C. Aubé,et al.  Diagnosis and Measurement of Liver Fibrosis by MRI in Bile Duct Ligated Rats , 2007, Digestive Diseases and Sciences.

[3]  P. Norton,et al.  Animal models of liver fibrosis. , 1996, Scandinavian journal of gastroenterology.

[4]  T. Moteki,et al.  Evaluation of hepatic lesions and hepatic parenchyma using diffusion‐weighted echo‐planar MR with three values of gradient b‐factor , 2006, Journal of magnetic resonance imaging : JMRI.

[5]  A. Aisen,et al.  Detection of liver fibrosis with magnetic cross‐relaxation , 1994, Magnetic resonance in medicine.

[6]  Bilal Tahir,et al.  Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. , 2009, AJR. American journal of roentgenology.

[7]  R. Knispel,et al.  Water content and proton spin relaxation time for neoplastic and non-neoplastic tissues from mice and humans. , 1974, Journal of the National Cancer Institute.

[8]  K. Minard,et al.  In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis , 2010, Journal of magnetic resonance imaging : JMRI.

[9]  F. Franconi,et al.  In vivo quantitative microimaging of rat spinal cord at 7T , 2000, Magnetic resonance in medicine.

[10]  J. Hazle,et al.  Chronic carbon tetrachloride and phospholipase D hepatotoxicity in rat: In vivo 1H magnetic resonance, total lipid analysis, and histology , 1990, Magnetic resonance in medicine.

[11]  M. Voigt.  Alcohol in hepatocellular cancer. , 2005, Clinics in liver disease.

[12]  J. Iredale,et al.  Modeling liver fibrosis in rodents. , 2005, Methods in molecular medicine.

[13]  M. Kanematsu,et al.  Diffusion‐weighted imaging of the liver: Optimizing b value for the detection and characterization of benign and malignant hepatic lesions , 2008, Journal of magnetic resonance imaging : JMRI.

[14]  R Mathur-De Vré,et al.  Biomedical implications of the relaxation behaviour of water related to NMR imaging. , 1984, The British journal of radiology.

[15]  Kevin C. Chan,et al.  Myocardial T2 quantitation in patients with iron overload at 3 Tesla , 2009, Journal of magnetic resonance imaging : JMRI.

[16]  P. Sijens.  Parametric exploration of the liver by magnetic resonance methods , 2009, European Radiology.

[17]  M. Cadioli,et al.  In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease , 2008, La radiologia medica.

[18]  Christian Bréchot,et al.  Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. , 2004, Gastroenterology.

[19]  C. Thomsen.  Quantitative magnetic resonance methods for in vivo investigation of the human liver and spleen. Technical aspects and preliminary clinical results. , 1996, Acta radiologica. Supplementum.

[20]  N. Afdhal,et al.  Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.

[21]  S. Friedman.  Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[22]  H. Morris,et al.  Nuclear magnetic resonance studies of cancer. VI. Relationship among spin-lattice relaxation times, growth rate, and water content of Morris hepatomas. , 1975, Journal of the National Cancer Institute.

[23]  M. Moerland,et al.  Is the magnetic resonance imaging proton spin‐lattice relaxation time a reliable noninvasive parameter of developing liver fibrosis? , 1988, Hepatology.

[24]  Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls , 2011, Pediatric Radiology.

[25]  Rajeev Sharma,et al.  Should trichrome stain be used on all post–liver transplant biopsies with hepatitis c virus infection to estimate the fibrosis score? , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  H. Kauczor,et al.  MR-Relaxometry of Myocardial Tissue: Significant Elevation of T1 and T2 Relaxation Times in Cardiac Amyloidosis , 2007, Investigative radiology.

[27]  D. Mitchell,et al.  Hepatic morphologic changes in cirrhosis: MR imaging findings , 2000, Abdominal Imaging.

[28]  G. Beaudoin,et al.  Diffusion‐weighted MR imaging of the liver of hepatitis C patients , 2003, NMR in biomedicine.

[29]  Lungen Lu,et al.  Assessment of fibrosis in chronic liver diseases , 2009, Journal of digestive diseases.

[30]  K. C. Hong,et al.  Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. , 2001, Radiology.

[31]  A. Gamst,et al.  Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis , 2007, Journal of magnetic resonance imaging : JMRI.

[32]  M. Colombo.  The role of hepatitis C virus in hepatocellular carcinoma. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[33]  J. Crespo,et al.  Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma , 2005, Obesity surgery.

[34]  J. Kucharczyk,et al.  Diffusion/perfusion MR imaging of acute cerebral ischemia , 1991, Magnetic resonance in medicine.

[35]  M. Moseley,et al.  Magnetic resonance imaging and spectroscopy of hepatic iron overload. , 1985, Radiology.

[36]  R. Constable,et al.  Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations--preliminary MR imaging in rats. , 2008, Radiology.

[37]  Jean-Luc Daire,et al.  Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. , 2003, Radiology.

[38]  M. Cohen,et al.  Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. , 1993, AJR. American journal of roentgenology.

[39]  C. Ganter,et al.  Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique , 2008, European Radiology.

[40]  N. Afdhal,et al.  Evaluation of Liver Fibrosis: A Concise Review , 2004, American Journal of Gastroenterology.

[41]  Isamu Ohashi,et al.  Apparent diffusion coefficient measurements with diffusion‐weighted magnetic resonance imaging for evaluation of hepatic fibrosis , 2005, Journal of magnetic resonance imaging : JMRI.

[42]  Claude B Sirlin,et al.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. , 2006, Radiology.

[43]  A. Luciani,et al.  Liver Cirrhosis : Intravoxel Incoherent Motion MR Imaging — Pilot Study 1 , 2008 .

[44]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[45]  I. Yamada,et al.  Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. , 1999, Radiology.

[46]  B. V. Van Beers,et al.  Assessment of diffusion‐weighted MR imaging in liver fibrosis , 2007, Journal of magnetic resonance imaging : JMRI.

[47]  R. Fontana,et al.  Noninvasive monitoring of patients with chronic hepatitis C , 2002, Hepatology.

[48]  Bachir Taouli,et al.  Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. , 2007, AJR. American journal of roentgenology.

[49]  N. Goldstein,et al.  Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens. , 2005, American journal of clinical pathology.

[50]  B. V. Van Beers,et al.  Liver fibrosis: non‐invasive assessment with MR elastography , 2006, NMR in biomedicine.

[51]  H. Tsukamoto,et al.  Experimental Models of Hepatic Fibrosis: A Review , 1990, Seminars in liver disease.

[52]  K. Chatamra,et al.  Controlled induction of cirrhosis in the rat. , 1983, British journal of experimental pathology.

[53]  T. S. St. Pierre,et al.  Detection limits for ferrimagnetic particle concentrations using magnetic resonance imaging based proton transverse relaxation rate measurements. , 2003, Physics in medicine and biology.

[54]  Bao-en Wang,et al.  Newly proposed fibrosis staging criterion for assessing carbon tetrachloride‐ and albumin complex‐induced liver fibrosis in rodents , 2008, Pathology international.

[55]  C. Zuiani,et al.  Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients , 2007, La radiologia medica.

[56]  C. Zuiani,et al.  Relevance of b‐values in evaluating liver fibrosis: A study in healthy and cirrhotic subjects using two single‐shot spin‐echo echo‐planar diffusion‐weighted sequences , 2008, Journal of magnetic resonance imaging : JMRI.

[57]  E. Wu,et al.  Breathhold multiecho fast spin‐echo pulse sequence for accurate R2 measurement in the heart and liver , 2009, Magnetic resonance in medicine.

[58]  V. Simplaceanu,et al.  Tissue water content and nuclear magnetic resonance in normal and tumor tissues. , 1975, Cancer research.

[59]  Alastair J. Martin,et al.  Chronic hepatitis: Role of diffusion‐weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation , 2008, Journal of magnetic resonance imaging : JMRI.

[60]  O. Nalcioglu,et al.  Statistical description of microcirculatory flow as measured with an MR method , 1993, Journal of magnetic resonance imaging : JMRI.

[61]  Katsuyoshi Ito,et al.  Cirrhosis: A Modified Caudate-to-Right-Lobe Ratio , 2001 .

[62]  P. Basser,et al.  MR diffusion tensor spectroscopy and imaging. , 1994, Biophysical journal.

[63]  J. Chen,et al.  In vivo magnetic resonance (MR) study of fatty liver: Importance of intracellular ultrastructural alteration for MR tissue parameters change , 2001, Journal of magnetic resonance imaging : JMRI.

[64]  N. Rofsky,et al.  MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. , 2004, Radiology.

[65]  Diego R. Martín.  Magnetic resonance imaging of diffuse liver diseases. , 2002, Topics in magnetic resonance imaging : TMRI.

[66]  N. J. Shah,et al.  Magnetic field dependence of the distribution of NMR relaxation times in the living human brain , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[67]  Richard L Ehman,et al.  MR elastography of the liver: preliminary results. , 2006, Radiology.

[68]  E. Wu,et al.  Diffusion tensor imaging of liver fibrosis in an experimental model , 2010, Journal of magnetic resonance imaging : JMRI.

[69]  M. Bronskill,et al.  T1, T2 relaxation and magnetization transfer in tissue at 3T , 2005, Magnetic resonance in medicine.

[70]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[71]  M. Arthur,et al.  Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. , 2002, Gastroenterology.

[72]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[73]  P. V. van Zijl,et al.  Diffusion Weighting by the Trace of the Diffusion Tensor within a Single Scan , 1995, Magnetic resonance in medicine.

[74]  S. Friedman.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. , 1993, The New England journal of medicine.

[75]  B R Rosen,et al.  Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.

[76]  Terence W Nixon,et al.  High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo , 2006, Magnetic resonance in medicine.

[77]  E. Wu,et al.  In vivo lipid profiling using proton magnetic resonance spectroscopy in an experimental liver fibrosis model. , 2011, Academic radiology.

[78]  Pierre-Yves Boëlle,et al.  Diffusion‐weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C , 2007, Hepatology.